CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105. A total of 37 filers reported holding CERULEAN PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $757,000 | -23.6% | 357,100 | -2.4% | 0.00% | 0.0% |
| Q1 2016 | $991,000 | -3.2% | 365,700 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,024,000 | -23.5% | 365,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,338,000 | -19.9% | 365,700 | +0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,670,000 | -37.4% | 363,100 | +22.7% | 0.00% | -50.0% |
| Q1 2015 | $2,666,000 | +45.2% | 295,900 | +0.2% | 0.00% | +33.3% |
| Q4 2014 | $1,836,000 | +48.1% | 295,200 | +0.5% | 0.00% | +50.0% |
| Q3 2014 | $1,240,000 | -26.3% | 293,800 | +1.3% | 0.00% | -33.3% |
| Q2 2014 | $1,682,000 | – | 290,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,437,441 | $6,612,000 | 6.88% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $15,123,000 | 6.74% |
| Cormorant Asset Management, LP | 551,354 | $2,536,000 | 0.34% |
| Deer VII & Co. Ltd. | 166,675 | $767,000 | 0.31% |
| Rock Springs Capital Management LP | 625,000 | $2,875,000 | 0.21% |
| WALL STREET ASSOCIATES | 475,000 | $2,185,000 | 0.21% |
| CLOUGH CAPITAL PARTNERS L P | 276,400 | $1,271,000 | 0.05% |
| TFS CAPITAL LLC | 103,648 | $477,000 | 0.05% |
| Granahan Investment Management | 332,225 | $1,528,000 | 0.04% |
| Northeast Financial Consultants Inc | 20,000 | $92,000 | 0.04% |